Anumana vs Implicity
Implicity is built for the device clinic. Its cloud platform reads pacemakers, ICDs, CRT devices and insertable monitors from Abbott, Biotronik, Boston Scientific, Medtronic and MicroPort, filters alerts and automates billing. SignalHF scores worsening heart failure from implant data and holds a 510(k), K230842, and the ILR ECG Analyzer received one in July 2026. The performance figures are the vendor's own, among them 79% fewer false positives on Medtronic recordings and 26% lower mortality than conventional remote monitoring. The two product papers have Implicity authors.
Anumana is bought by a hospital's cardiology department to read a standard 10-second 12-lead ECG, which any patient can have. A 2026 pragmatic trial of the vendor's decision support for guideline-directed management appeared in Am Heart J Plus.
A heart failure program with few implanted patients has no implant data for SignalHF to score. An electrophysiology team following mixed-brand pacemakers needs data that Anumana does not read.
Decision support · Reviewed November 2, 2026
Anumana
by Anumana
ECG-AI software that flags low ejection fraction, pulmonary hypertension and cardiac amyloidosis from standard 12-lead ECGs.
Implicity
by Implicity · founded 2016
Cloud platform for remote monitoring of pacemakers and ICDs, with AI alert filtering and heart failure risk scoring for device clinics.
When to pick each one
Anumana
- Input is a standard 12-lead ECG
- Pragmatic trial of its own tool published in 2026
Implicity
- Monitors Abbott, Biotronik, Boston Scientific, Medtronic and MicroPort devices
- SignalHF heart failure score cleared as K230842
Score
Each row shows points earned of points available under the published rubric.
Anumana
37of 100
Implicity
36of 100
| Dimension | Anumana | Implicity | Difference |
|---|---|---|---|
| FDA clearance | 12 / 12 | 12 / 12 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 5.6 | 0 / 5.6 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 0 / 4.8 | 0 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 14.7 / 21 | 8.4 / 21 | +6.3 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 0 / 6 | 6 / 6 | -6 |
Scroll horizontally to see every column.
Pricing
Anumana
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. The pricing page returns 404; the site offers a demo request only. |
Implicity
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Anumana
FDA decisions
K253801 (opens in new tab)510(k)2026-04-07
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040)
K252360 (opens in new tab)510(k)2026-03-28
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm (1020)
K250652 (opens in new tab)510(k)2025-07-28
ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010)
K232699 (opens in new tab)510(k)2023-09-28
Low Ejection Fraction AI-ECG Algorithm
Peer-reviewed
3 PubMed records name Anumana.
- A Pragmatic Trial Evaluating the Impact of the Anumana Clinical Decision Support Tool for Guideline-Directed Management of Heart Failure (ACT-HF): Clinical trial design and methods. (opens in new tab)
- Comment on "A pragmatic trial evaluating the impact of the anumana clinical decision support tool for guideline-directed management of heart failure (ACT-HF): Clinical trial design and methods". (opens in new tab)
- Identification and risk stratification of coronary disease by artificial intelligence-enabled ECG. (opens in new tab)
Implicity
FDA decisions
K253463 (opens in new tab)510(k)2026-07-02
ILR ECG Analyzer (IM007)
K230842 (opens in new tab)510(k)2023-10-25
SignalHF (IM008)
K210543 (opens in new tab)510(k)2021-11-03
IM007
Peer-reviewed
1 PubMed record names Implicity.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Anumana | Implicity |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | 2016 |
| HQ | US | FR |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.